Neurology Search
Neurology Neurology
neuropathic%20pain
NEUROPATHIC PAIN
Neuropathic pain is the sensation of pain due to abnormal discharges of impaired or injured neural structures in the peripheral &/or central nervous system.
It is characterized by hyperesthesia, hyperalgesia and allodynia.
Common neuropathic pain syndromes are central neuropathic pain, painful diabetic peripheral neuropathy, postherpetic neuralgia, trigeminal neuralgia, postsurgical neuropathic pain, HIV-related neuropathy, lumbosacral radiculopathy and complex regional pain syndrome.
Drug Information

Indication: Neuropathic pain in adults. Adjunctive therapy in adults w/ partial seizures w/ or w/o secondary generalisatio...

Indication: Peripheral neuropathies. Inj: Megaloblastic anaemia due to vit B12 deficiency.

Indication: Adjunctive therapy in treatment of partial seizures w/ & w/o secondary generalization in adults & chil...

Indication: Moderate to severe pain.

Indication: Severe acute & chronic pain. Painful diagnostic or therapeutic measures.

Indication: Moderate to severe acute & chronic pain & in painful diagnostic measure & surgery.

Indication: Local anesth of the mucous membrane.

Indication: Major depressive disorder, generalized anxiety disorder. Management of diabetic peripheral neuropathic pain.

Daneuron
vitamin B1 + vitamin B12 + vitamin B6

Indication: Neurological disorders & metabolic function disturbances including diabetic polyneuropathy, alcoholic peri...

Indication: Infiltration & nerve-block anesth in dentistry.

1  /  8
1  /  8
Editor's Recommendations
Most Read Articles
Aerobics improves cognitive, motor functions in seniors with cognitive impairment
Audrey Abella, 15 Aug 2018
Supervised aerobic-strength training improved cognitive and motor functions among elderly individuals with mild cognitive impairment (MCI), according to studies presented at AAIC 2018.
Perinatal maternal depressive symptoms linked to child brain development
12 May 2019
A consistent association exists between perinatal maternal depressive symptoms and child brain development assessed 10 years later, suggests a recent study.
Amiselimod shows promise as treatment for multiple sclerosis
02 Sep 2016
Results of a study show that patients with relapsing-remitting multiple sclerosis may benefit from the new sphingosine 1-phosphate 1 inhibitor drug amiselimod.